6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine

C22H24F2N8 — CID 156846826

IUPAC6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine
SMILESCN1CCC(n2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncc(C4CC4)nc32)CC1
InChIInChI=1S/C22H24F2N8/c1-31-8-6-13(7-9-31)32-22-20(25-10-16(28-22)12-2-3-12)21(30-32)26-11-17-27-15-5-4-14(23)18(24)19(15)29-17/h4-5,10,12-13H,2-3,6-9,11H2,1H3,(H,26,30)(H,27,29)
InChIKeyCZLAEMHDAYEHQP-UHFFFAOYSA-N
MW438.49 g/mol
LogP3.74
Rot. Bonds5

About 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine

6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine (PubChem CID 156846826) has the molecular formula C22H24F2N8 and a molecular weight of 438.49 g/mol. Its IUPAC name is 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine.

Molecular Properties

Compound Name6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine
PubChem CID156846826
Molecular FormulaC22H24F2N8
Molecular Weight438.49 g/mol
Exact Mass438.21
IUPAC Name6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine
SMILESCN1CCC(n2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncc(C4CC4)nc32)CC1
InChIInChI=1S/C22H24F2N8/c1-31-8-6-13(7-9-31)32-22-20(25-10-16(28-22)12-2-3-12)21(30-32)26-11-17-27-15-5-4-14(23)18(24)19(15)29-17/h4-5,10,12-13H,2-3,6-9,11H2,1H3,(H,26,30)(H,27,29)
InChIKeyCZLAEMHDAYEHQP-UHFFFAOYSA-N
XLogP3.74
TPSA87.55 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms32
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500438.49
LogP ≤ 53.74
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine?
The IUPAC name of 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine (CID 156846826) is 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine.
What is the SMILES notation for 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine?
The canonical SMILES for 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine is CN1CCC(n2nc(NCc3nc4c(F)c(F)ccc4[nH]3)c3ncc(C4CC4)nc32)CC1.
What is the InChIKey of 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine?
The InChIKey is CZLAEMHDAYEHQP-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H24F2N8/c1-31-8-6-13(7-9-31)32-22-20(25-10-16(28-22)12-2-3-12)21(30-32)26-11-17-27-15-5-4-14(23)18(24)19(15)29-17/h4-5,10,12-13H,2-3,6-9,11H2,1H3,(H,26,30)(H,27,29).
What are the key properties of 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine?
6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine has a molecular weight of 438.49 g/mol, XLogP of 3.74, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 6-cyclopropyl-N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-1-(1-methylpiperidin-4-yl)pyrazolo[3,4-b]pyrazin-3-amine is sourced from PubChem (CID 156846826), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).